YL System (190171583)

  https://cordis.europa.eu/project/id/190171583

  Horizon Europe (2021-2027)

  A pioneer clinical trial management system to automatically collect, review and analyse prospective clinical trial data to prompt faster development of novel therapies.

  Strategic Digital and Health Technologies (HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01)

  databases

  2022-09-01 Start Date (YY-MM-DD)

  2025-02-28 End Date (YY-MM-DD)

  € 3,566,061

  Description

YonaLink (YL) is an Israeli company established in 2018 with the mission to disrupt the €46B clinical research market by connecting the world of Prospective Clinical Trial Data. To this end, YL is developing the YL System, a platform to migrate clinical research data saved in the patient health records, from medical centres to research database(s) in an automated, secure, validated, trusted and error-free way. The company has secured over €1.8M in the development of the YL System, reaching TRL 7 with pilot trials implementing it at Soroka MC (Clalit Health Insurance leading hospital) and in Sheba MC. The trials have confirmed the accuracy in migrating patients’ de-identified data from the EHR to the trial DB. EIC support will allow YL to finish optimization and validate the YL System in a multicentre–multinational pilot, demonstrating the advantage of automatic data transfer from EHR to the prospective trial database to all the clinical trial stakeholders in the EU.

  Complicit Organisations

1 Israeli organisation participates in YL System.